Company Filing History:
3 out of 17 
2 out of 3 
1 out of 832,880 Years Active: 2000-2007
Title: **Innovations in Therapeutics: The Work of Christine L. O'Day**
Introduction
Christine L. O'Day is an accomplished inventor based in Mountlake Terrace, Washington, known for her significant contributions to the field of therapeutic development. With six patents to her name, her innovations primarily focus on polyamine analogues, which have potential applications in treating serious conditions such as cancer and post-angioplasty injury.
Latest Patents
Among her latest patents is a groundbreaking development concerning polyamine analogues as therapeutic and diagnostic agents. These novel inhibitors of polyamine transport are noteworthy for their inhibition constants, which are two orders of magnitude lower than those of existing compounds. O'Day's research details the usefulness of these polyamine analogues as pharmaceutical agents in inhibiting polyamine transport or other polyamine binding proteins. The innovative chemical synthetic methods she has disclosed include the creation of a combinational polyamine library, yielding analogues with desirable activities for both diagnostics and therapeutic applications. Furthermore, her invention includes high throughput screening assays that facilitate drug discovery targeting the polyamine system.
Career Highlights
Christine L. O'Day has had a distinguished career, holding pivotal roles in reputable companies such as Mediquest Therapeutics, Inc. and Oridigm Corporation. Her experience in these organizations has contributed to her success as an inventor, particularly in the realm of pharmaceutical innovations.
Collaborations
Throughout her career, O'Day has collaborated with various professionals, including notable colleagues like Nicolaas M. J. Vermeulin and Heather K. Webb. These collaborations have fostered a rich environment for the exchange of ideas and have propelled her inventive processes, leading to her successful patent submissions.
Conclusion
Christine L. O'Day exemplifies the spirit of innovation in the biomedical field. Her work on polyamine analogues not only showcases her inventive capabilities but also highlights the importance of collaboration in bringing forth significant advances in medical therapeutics. As she continues her work, her contributions are poised to make a lasting impact on the treatment of diseases where polyamines play a crucial role.